User profiles for JR Arribas

Jose Arribas

Hospital La Paz
Verified email at salud.madrid.org
Cited by 25527

Cytomegalovirus encephalitis

JR Arribas, GA Storch, DB Clifford… - Annals of internal …, 1996 - acpjournals.org
Arribas and colleagues [68] found that patients with ventriculoencephalitis, radiculomyelitis,
Arribas and colleagues cautioned that the implication of low levels of cytomegalovirus DNA …

[HTML][HTML] Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain

…, F Arnalich, JR Arribas - The Lancet …, 2015 - thelancet.com
… Dr Jose R Arribas, MD Jose R Arribas … Correspondence to: Dr Jose R Arribas, Infectious
Diseases Unit, Department of Internal Medicine, La Paz-Carlos III University Hospital, IdiPAZ, …

[HTML][HTML] The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis

İ Kayı, B Madran, Ş Keske, Ö Karanfil, JR Arribas… - Clinical microbiology …, 2021 - Elsevier
Background The prevalence of SARS-CoV-2 infection among health care workers (HCWs)
provides information about the spread of COVID-19 within health care facilities, and the risk …

[HTML][HTML] Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV

JE Gallant, E DeJesus, JR Arribas… - … England Journal of …, 2006 - Mass Medical Soc
Background Durable suppression of replication of the human immunodeficiency virus (HIV)
depends on the use of potent, well-tolerated antiretroviral regimens to which patients can …

[HTML][HTML] Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled …

…, C Pérez-Ingidua, AG de la Cámara, JR Arribas… - The Lancet, 2021 - thelancet.com
Background To date, no immunological data on COVID-19 heterologous vaccination schedules
in humans have been reported. We assessed the immunogenicity and reactogenicity of …

[HTML][HTML] Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

…, J Carratala, J Pachón, M Yllescas, JR Arriba… - Clinical Microbiology …, 2020 - Elsevier
Objectives To analyse the characteristics and predictors of death in hospitalized patients
with coronavirus disease 2019 (COVID-19) in Spain. Methods A retrospective observational …

Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study

…, S Moreno, A Díaz, E Martínez, JR Arribas… - Annals of internal …, 2020 - acpjournals.org
Background: The incidence and severity of coronavirus disease 2019 (COVID-19) among
HIV-positive persons receiving antiretroviral therapy (ART) have not been characterized in …

[HTML][HTML] Clinical management of Ebola virus disease in the United States and Europe

…, T Grünewald, M Jacobs, JR Arribas… - … England Journal of …, 2016 - Mass Medical Soc
Background Available data on the characteristics of patients with Ebola virus disease (EVD)
and clinical management of EVD in settings outside West Africa, as well as the …

[HTML][HTML] A cohort of patients with COVID-19 in a major teaching hospital in Europe

…, JJ Rios, MA Hernán, J Frías, JR Arribas… - Journal of clinical …, 2020 - mdpi.com
Background: Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in
January 2020, the epidemic has grown rapidly, with the greatest impact on the region of …

Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications

…, JR Rey, JJ Rios, JR Arribas… - European journal of …, 2020 - Wiley Online Library
Aims Data on the impact of COVID‐19 in chronic heart failure (CHF) patients and its
potential to trigger acute heart failure (AHF) are lacking. The aim of this work was to study …